Accelerated Approval?, page-25

Bringing this thread back to topic.

My head is still spinning that Justaposer said that because Starpharma were appealing/talking to the FDA to try to overturn the negative VivaGel decision, and because the chairman has been buying shares, this was somehow evidence that Starpharma are going to seek or were already in the process of seeking accelerated approval for DEP in cancer indications.

Holy heck, what !? Can I please have what he’s having? Must be a decent trip.

I seem to remember that Justaposer also believed adamantly that DEP-Dudetaxel was going to alter the cancer treatment landscape. Instead it’s basically been shelved.

Good one.